Surgeons were able to identify and remove a greater number of cancerous nodules from lung cancer patients when combining intraoperative molecular imaging (IMI) — through the use of a contrast agent that makes tumor cells glow during surgery — with preoperative positron emission tomograph y (PET) scans. This study shows how effective the combination of IMI with the tumor-glowing agent can be when combined with traditional PET imaging.